The Genome Sciences group provides researchers with multiple complementary tools for genome interrogation including: rapid scanning of genomes for new mutations causing relevant phenotypes;mapbuilding using microsatellite and/or SNP markers, including data analysis and new marker development; high throughput microsatellite allele typing and SNP genotyping;DNA sequencing;and highly purified DNA from JAX mouse strains that is used routinely in experiments as controls. Genome Sciences (GS) comprises the following services: 1) Allele Typing &Sequencing;2) Single Nucleotide Polymorphism genotyping;3) Fine Mapping;and 4) the DNA Resource. GS provides researchers with access to stateof- the-art instrumentation, reagents and expertise for genome scanning, allele typing, and sequencing, including support in project planning and data analysis. Sequencing and Allele typing have previously received CCSG support. CCSG funds are now requested for the SNP Genotyping Service and the Fine Mapping Laboratory, which have been in operation for 2 and 3 years, respectively, with well established records of delivering additional functionality as required by Cancer Center members. Operating since 1982, the DNA Resource maintains and distributes highly purified genomic DNA, which is used by virtually all Center researchers for controls in genome analysis experiments including the cloning of spontaneous mutations. Genome Sciences, which occupies 847 ft2 of laboratory space in Research Laboratory Unit 4 and the Genetic Resources Building, employs four molecular technologists, and four laboratory technicians all reporting to a senior manager molecular geneticist. Project Leader Jurgen Naggert, a molecular geneticist, oversees this fee-for-service operation. He communicates with the Cancer Center users, Service staff and Center Administration to ensure that research needs are met in the most efficient, cost-effective and technically current manner.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA034196-27
Application #
8113198
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
27
Fiscal Year
2010
Total Cost
$244,141
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Linn, Sarah C; Mustonen, Allison M; Silva, Kathleen A et al. (2018) Nail abnormalities identified in an ageing study of 30 inbred mouse strains. Exp Dermatol :
Hosur, Vishnu; Farley, Michelle L; Burzenski, Lisa M et al. (2018) ADAM17 is essential for ectodomain shedding of the EGF-receptor ligand amphiregulin. FEBS Open Bio 8:702-710
Becker, Timothy; Lee, Wan-Ping; Leone, Joseph et al. (2018) FusorSV: an algorithm for optimally combining data from multiple structural variation detection methods. Genome Biol 19:38
Wang, Qianghu; Hu, Baoli; Hu, Xin et al. (2018) Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell 33:152
Richter, Wolfgang F; Christianson, Gregory J; Frances, Nicolas et al. (2018) Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. MAbs 10:803-813
Tamura, Ryo; Yoshihara, Kosuke; Saito, Tetsuya et al. (2018) Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions. Oncogenesis 7:4
Rutherford, Sarah C; Fachel, Angela A; Li, Sheng et al. (2018) Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations. Blood 132:e13-e23
Barthel, Floris P; Wesseling, Pieter; Verhaak, Roel G W (2018) Reconstructing the molecular life history of gliomas. Acta Neuropathol 135:649-670
Kim, Hyunsoo; Kumar, Pooja; Menghi, Francesca et al. (2018) High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts. Sci Rep 8:17937
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:

Showing the most recent 10 out of 1156 publications